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Percutaneous transluminal angioplasty (PTA) has
been proposed as a safe, effective, less expensive alter-
native to lower extremity arterial bypass graft surgery
for treating limb-threatening ischemia and claudica-
tion. The effectiveness of PTA in the treatment of aor-
toiliac occlusive disease is well established, with good
long-term patency achieved in the common iliac
arteries.1,2 The less invasive nature of PTA and the
reports of excellent patency in selected cases3-5 have
resulted in increasing use of this modality as a prima-
ry treatment of lower extremity arterial stenoses and
occlusions. Early success with PTA at our institution
in the treatment of focal stenoses in the popliteal
artery and below6,7 led us to expand the indications
for PTA to include longer, more distal lesions with
less favorable runoff, particularly in high-risk patients
and those whose surgical options are less promising.
The value of PTA in this group of patients with limb-
salvage indications has not been established. The pub-
lished reports of infrainguinal PTA in patients with
threatened limbs have shown a range of results, with
1-year patency ranging from 12% to 70%.2,8-10,11
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Conclusion: Common iliac artery PTA is justified in most cases in which it is feasible.
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The results of PTA in treating limb-threatening
ischemia with these broadened indications were
evaluated. Patients with claudication were specifical-
ly excluded. The success of PTA was determined by
means of noninvasive vascular laboratory criteria,
patency by means of pulse examination, the need for
subsequent bypass grafting (across the lesion), and
limb salvage.
METHODS
All 257 patients who had 1 or more PTAs for
limb salvage indications (Fontaine grade II or III)12
at Montefiore Medical Center between 1992 and
1995 were identified and included in the study on
an intention-to-treat basis. During this same period,
25 patients received PTA for claudication, but they
were excluded from this study.
All patients had diagnostic angiography performed
by an interventional radiologist, and the decision to
proceed with PTA was made after joint consultation
between the radiologist and vascular surgeon. Most
angioplasties were performed at the time of the initial
arteriogram. The runoff was recorded as poor (no
direct runoff to the foot, grade 0 to 1) or good (direct
flow to the foot, grade 2 to 3) by the radiologist. The
presence of a stenosis or occlusion was recorded, as
was the treatment of multiple lesions.
All patients were evaluated with quantitative
pulse volume recordings (PVRs) and ankle brachial
indices (ABIs) before undergoing diagnostic arteri-
ography. Patients were evaluated by pulse examina-
tion, PVRs, and ABIs at 1 and 6 weeks and then at 3
month intervals after PTA. Hemodynamic success
was defined as an increase in the PVR amplitude of 5
mm or more or an increase in ABI more than 0.15,
as compared with the preangioplasty values.12,13
However, clinically we have relied on the PVR ampli-
tude, because this value evaluates both patients with
calcific (noncompressible) and compressible arteries.
Likewise, a decrease of 5 mm in the PVR or a
decrease in ABI of 0.15, as compared with the first
postangioplasty value, was considered an indication
of failure and was confirmed by means of color
duplex evaluation, arteriography, or both.
Age, sex, history of diabetes mellitus, and previous
vascular procedures were recorded for each patient.
Subsequent procedures above, across, or below the
index lesion originally treated by PTA were recorded.
The performance of a second angioplasty, bypass
grafting across the lesion, or recurrence of symptoms
were considered clinical failures of angioplasty.
Clinical success was defined as healing of an ischemic
lesion or improvement in rest pain. If a bypass graft-
ing across the lesion was performed after an unsuc-
cessful PTA, a second arteriogram was obtained to
reevaluate the anatomy and confirm angioplasty fail-
Fig 2. Cumulative patency rates at 1 year for superficial
femoral artery PTA, according to lesion length. No satis-
tically significant differences were noted.
Fig 1. Cumulative patency rates for angioplasty of the
iliac artery at 1 year. The primary patency rate was 87% for
common iliac PTA vs 56% for external iliac PTA. This dif-
ference was statistically significant (P < .05).
Fig 3. Cumulative 1-year patency rates for above-knee
popliteal artery PTA, according to lesion length. No sta-
tistically significant differences were noted.
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ure, unless the angioplasty failure was immediate and
obvious at the time of its performance.
Kaplan-Meier life-table analysis was used to
assess patency for all anatomic levels of balloon
angioplasty and log-rank analysis was performed to
compare life-tables by means of the SPSS statistical
software. Significance levels were set at P < .05.
RESULTS
From 1992 to 1995, 307 PTAs were performed
in 257 patients for limb-salvage indications associat-
ed with stenoses or occlusions. Of these 307 PTAs,
85 were iliac PTAs done in 72 patients, and the
remaining 222 were infrainguinal PTAs performed in
185 patients. Sixty-seven percent of patients were
women, 43% were men, and the average age of
patients was 69 years. One hundred sixty-one (63%)
patients had diabetes mellitus, and 32 (12%) had
renal failure. Seventeen patients (7%) were lost to fol-
low-up at some point in their post-treatment course.
The 1-year patency rate, based on pulse exami-
nation and hemodynamic criteria, for external iliac
PTAs (56%) was significantly lower (P < .05) than
that of common iliac PTAs (86%; Fig 1). Of the 72
patients undergoing common or external iliac artery
PTA, 30 also had an ipsilateral infrainguinal bypass
graft, and 5 had a femoral-femoral bypass grafting
performed distal to the PTA. The 1-year primary
patency rate of these bypass grafts was 84%. In addi-
tion, 5 PTAs (3 common, 2 external) were per-
formed above existing infrainguinal bypass grafts to
treat inflow lesions detected by means of graft sur-
veillance. In the remaining 37 patients treated with
iliac PTA alone, clinical success was defined as reso-
lution of rest pain or salvage of the foot 1 year after
85% of common iliac and 75% of external iliac PTAs.
When PTAs were performed below the inguinal
ligament, the results were markedly worse. The 1-
year PTA patency rates, based on hemodynamic cri-
teria, were 13% in the superficial femoral artery
(SFA), 11% in the popliteal artery, and 13% in the
tibial or peroneal arteries. Initial hemodynamic suc-
cess at the ankle was obtained in less than 40% of
patients who had an infrainguinal PTA. After super-
ficial femoral PTA, 35 of 66 patients (53%) showed
hemodynamic improvement at the calf, and 21 of 66
(32%) showed improvement at the ankle. After
popliteal PTA, 31 of 75 patients (41%) had initial
hemodynamic improvement at the calf, and 18 of 75
(24%) had it at the ankle. After PTA at the tibial
level, 22 of 66 patients (33%) had initial hemody-
namic improvement at the ankle.
Of the 67 patients having SFA angioplasty, 30
required an ipsilateral infrainguinal bypass grafting
within a year after the PTA; the 1-year patency rate
for these bypass grafts was 74%. In the 75 patients
undergoing popliteal PTA, 29 required an ipsilateral
infrainguinal bypass grafting within 1 year of the
PTA, and these bypass grafts had a 1-year patency
rate of 72%. Clinical success for all infrainguinal
PTAs was 15% or less after 1 year. Even with the
benefits of subsequent bypass graft surgery, limb sal-
vage rates were 95%, 73%, and 25% for the SFA,
popliteal, and tibial PTAs, respectively (Table I).
Three of the 70 SFA PTAs were considered patent
by means of hemodynamic criteria in patients requir-
ing a below-knee amputation to control infection.
A number of other factors thought to be impor-
tant for the success of angioplasty were examined by
life-table comparisons. These included whether the
lesion was stenotic or occlusive, the length of the
lesion, and the quality of the outflow at the time of
angioplasty. Life-table comparison of angioplasty
results based on lesion length showed no significant
Fig 4. Cumulative 1-year patency rates for below-knee
popliteal artery PTA, according to lesion length. No sta-
tistically significant differences were noted.
Fig 5. Cumulative 1-year patency rates for tibial artery
PTA, according to lesion length. No statistically significant
differences were noted.
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differences (Figs 2 and 5). Similar comparisons
based on occlusion versus stenoses or quality of out-
flow also showed no significant differences.
DISCUSSION
The use of PTA as a primary treatment for aor-
toiliac and lower extremity occlusive disease has
been increasing in recent years because of advances
in technology in endovascular therapy.14,15 This
increased use of PTA is related to the perceived
lower morbidity and cost and reported results that
are similar to those of bypass graft surgery. The
excellent patency results of common iliac artery
angioplasty have largely formed the basis for this
increased use of PTA, which has reduced the need
for the more invasive aortofemoral bypass grafting.
The results of our study confirm the utility of com-
mon iliac PTA in treating either occlusions or
stenoses in the limb-salvage setting, and PTA can be
effective either as the sole therapy or to provide
inflow for a needed infrainguinal bypass graft.
As the site of angioplasty moves more distally in
the arterial tree, the benefits become less clear. In
the external iliac artery, our 1-year patency rate was
56%, which is lower than patency rates of femoro-
femoral bypass grafts (61% to 79%), a procedure
with a relatively low morbidity and mortality.16,17
One-year patency rates of infrainguinal PTAs have
reportedly ranged from 12% to 100%, with the lower
patency rates reported when the indication for treat-
ment was limb salvage and the higher patency rates
reported when patients were largely treated for inter-
mittent claudication.10,18-20 Hunink et al2 reported a
meta analysis of patency results of percutaneous and
surgical revascularization for femoropopliteal arterial
disease. A 5-year patency rate of 68% was noted after
PTA was performed on a stenotic femoropopliteal
lesion to treat claudication, whereas the 5-year paten-
cy rate was only 12% when PTA of an occlusive lesion
was performed to treat critical ischemia. Treiman et
al21 reported on the results of below-knee popliteal
and tibial artery PTAs for limb salvage in 25 patients
and found a high rate of lesion and symptom recur-
rence that required subsequent surgical revasculariza-
tion. In addition, an analysis of cost did not demon-
strate a savings with PTA when compared with bypass
graft surgery.21 London et al9 treated 54 patients with
limb-threatening ischemia by means of PTA alone
with apparently better results and reported a 2-year
symptomatic improvement rate of 77%. However,
these patients represented only 23% of the 232
patients treated by this group for limb-threatening
ischemia. Currie and his colleagues22 noted that 22 of
23 femoropopliteal PTAs of lesions longer than 5 cm
failed within 6 months in patients with critical
ischemia.22 In contrast, PTAs of lesions less than 5 cm
had better results, with 10 of 15 patent at 6 months.
A recent report by Stanley et al23 on 176 patients
treated by means of PTA of SFA and popliteal artery
lesions showed a 2-year cumulative patency of 46%.
However, 74% of these patients were treated for inter-
mittent claudication. These discrepant results make
various reports difficult to interpret. Moreover, many
studies continue to report technical or symptomatic
success as an end point.
The technical success rate of angioplasty is often
reported to be in the range of 90%.23-26 We had sim-
ilar technical success; however, our initial hemody-
namic success, defined as an increase in the ABIs or
PVRs at the ankle for infrainguinal PTA, occurred in
less than 40% of our patients. The failure of “techni-
cally successful” PTAs to improve PVRs may be
caused by an early occlusion of the dilated lesion or
such extensive occlusive disease in the outflow ves-
sels that even a successful PTA produced no hemo-
dynamic improvement distally. In this regard, the
importance of establishing direct arterial flow in the
foot to heal gangrenous lesions has been stressed by
our group, as well as others.14
The 1-year PTA success rate in our series was
similar whether we used the need for a second PTA,
the requirement for a subsequent bypass grafting, or
hemodynamic improvement by means of noninva-
sive studies as an end point. Surprisingly, lesion
length or occlusion vs stenosis were not predictive of
PTA patency or success.
The major factor accounting for the differences
in the results of our study and the better results pre-
Table I. Life-table analysis: Infrainguinal arteries
Common iliac External iliac Superficial femoral Popliteal Tibial
artery PTA artery PTA artery PTA artery PTA artery PTA
Number of cases 50 35 70 75 66
1-year patency rates 86% 56% 13% 11% 13%
1-year limb-salvage rates 96% 96% 95% 73% 25%
PTA, Percutaneous transluminal angioplasty.
viously reported by us and by other authors appears
to be patient selection.6,7,27,28 Our early enthusiasm
for these less-invasive procedures in carefully select-
ed patients prompted us to expand the indications
to include patients with longer occlusions, previ-
ously failed bypass grafts, or diffusely diseased arter-
ies. Our hope was that these expanded indications
for PTA would prove to be effective. This has not
been the case for PTA below the inguinal ligament.
Accordingly, we believe these procedure are gener-
ally contraindicated in the limb-salvage setting, in
which patients generally have complex multilevel
disease.
Despite the poor 1-year patency rates after
infrainguinal PTA in patients with threatened limbs,
the procedure may still have some value in the limb-
salvage setting, especially when patients present an
extraordinary surgical risk. In this circumstance,
some gangrenous or ulcerating lesions can heal and
remain healed after the PTA fails, possibly justifying
the procedure. In addition, a small subset of patients
in our series had a PTA of a focal SFA stenosis fol-
lowed by a popliteal to distal artery bypass grafting,
which proved to have durable patency. Although the
decision to perform an infrainguinal PTA for limb-
salvage indications may be reasonable in an occa-
sional case, we do not believe the indications for
infrainguinal PTA should be expanded in patients
with threatened limbs beyond patients with short
stenotic lesions. The results are just too poor.
Additional disadvantages of infrainguinal PTA
include the need for a second angiogram as a means
to confirm failure when hemodynamic improvement
does not occur and the delay of a needed bypass
graft, which can lead to progression of ischemia or
gangrene with greater tissue loss. This delay was
seen in our study in the large number of patients
who underwent a bypass grafting within a year after
their PTA, and it has also been seen by other
authors.21 When infrainguinal PTA is performed and
a poor hemodynamic response occurs or duplex evi-
dence of failure is observed, the appropriate bypass
graft should be performed as soon as possible. This
aggressive approach will avoid delay and progression
of necrosis and make the overall limb salvage efforts
less costly and more effective.
REFERENCES
1. Johnston KW. Iliac arteries: reanalysis of results of balloon
angioplasty. Radiology 1993;186:207-12.
2. Hunink MM, Wong JB, Donaldson MC, et al. Patency
results of percutaneous and surgical re-vascularization for
femoropopliteal arterial disease. Med Decis Making 1994;
14:71-81.
JOURNAL OF VASCULAR SURGERY
1070 Parsons et al December 1998
3. Johnson KW. Femoral and popliteal arteries: reanalysis of
results of balloon angioplasty. Radiology 1992;183:767-71.
4. Gallino A, Mahler F, Probst P, et al. Percutaneous translumi-
nal angioplasty of the arteries of the lower extremity: a 5-year
follow-up. Circulation 1984;70:619-23.
5. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angio-
plasty: factors influencing long-term success. Circulation J Am
Heart Assoc 1991;83:I-70-I-80.
6. Sprayregen S, Sniderman KW, Sos TA, et al. Popliteal artery
branches: percutaneous transluminal angioplasty. AJR Am J
Roentgenol 1980;135:945-50.
7. Bakal CW, Sprayregen S, Scheinbaum K, et al. Percutaneous
transluminal angioplasty of the infrapopliteal arteries: results
in 53 patients. AJR Am J Roentgenol 1990;154:171-4.
8. Jeans WD, Cole SFA, Horrocks M, Baird RN. Angioplasty
gives good results in critical lower limb ischemia. A 5-year
follow-up in patients with known ankle pressure and diabetic
status having femorpopliteal dilations. BR J Radiol 1994;67:
123-8.
9. London NJ, Varty K, Sayers RD, et al. Percutaneous translu-
minal angioplasty for lower-limb critical ischaemia. Br J Surg
1995;82:1232-5.
10. Blair JM, Gewertz BL, Moosa H, et al. Percutaneous trans-
luminal angioplasty versus surgery for limb-threatening
ischemia. J Vasc Surg 1989;9:698-703.
11. Matsi PJ, Manninen HI, Suhonen MT, et al. Chronic critical
lower-limb ischemia: prospective trial of angioplasty with
1–36 months follow-up. Radiology 1993;188:381-7.
12. Ahn SS, Rutherford RB, Becker GJ, et al. Reporting stan-
dards for lower extremity arterial endovascular procedures. J
Vasc Surg 1993;6:1103-7.
13. Gerlock AJ Jr, Giyanani VL, Krebs C. Noninvasive testing of
transluminal angioplasty for lower extremity ischemia. In:
Wickland E, editor. Textbook of applications of noninvasive
vascular techniques. 1st ed. Philadelphia: WB Saunders; 1988.
p. 381-412.
14. Veith FJ, Gupta SK, Wengerter KR, et al. Changing arte-
riosclerotic disease patterns and management strategies in
lower-limb threatening ischemia. Ann Surg 1990;212:402-12.
15. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty,
bypass surgery, and amputation in the management of
peripheral vascular disease. N Engl J Med 1991;325:556-62.
16. Schneider JR, Besso SR, Walsh DB, et al. Femorofemoral ver-
sus aortobifemoral bypass: outcome and hemodynamic
results. J Vasc Surg 1994;19:43-57.
17. Hanafy M, McLoughlin GA. Comparison of iliofemoral and
femorofemoral crossover bypass in the treatment of unilater-
al iliac arterial occlusive disease. Br J Surg 1991;78:1001-2.
18. Becker GJ, Katzen BT, Dake MK. Noncoronary angioplasty.
Radiology 1989;170:921-40.
19. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal
angioplasty versus operation for peripheral arteriosclerosis. J
Vasc Surg 1989;9:1-9.
20. Murray RR, Hewes RC, White RI, et al. Long-segment
femoropopliteal stenosis: is angioplasty a boon or a bust?
Radiology 1987;162:473-6.
21. Treiman GS, Treiman RL, Ichikawa L, et al. Should percuta-
neous transluminal angioplasty be recommended for treat-
ment of infrageniculate popliteal artery or tibioperoneal
trunk stenosis? J Vasc Surg 1995;22:457-65.
22. Currie IC, Wakeley CJ, Cole SFA, et al. Femoropopliteal
angioplasty for severe limb ischaemia. Br J Surg 1994;
81:191-3.
23. Stanley B, Teague B, Raptis S, et al. Efficacy of balloon angio-
JOURNAL OF VASCULAR SURGERY
Volume 28, Number 6 Parsons et al 1071
plasty of the superficial femoral artery and popliteal artery in
the relief of leg ischemia. J Vasc Surg 1994;23:679-85.
24. Perkins JTM, Collins JC, Morris PJM. Angioplasty versus
exercise for stable claudication: long-term results of a
prospective randomized trial. Br J Surg 1995;82:557-8.
25. Johnston KW, Roe M, Hogg-Johnson SA, et al. Five-year
results of a prospective study of percutaneous angioplasty.
Ann Surg 1987;206:403-13.
26. Morgenstern BR, Getrajdman GI, Laffey KJ, et al. Total
occlusions of the femoropopliteal artery: high technical suc-
cess rate of conventional balloon angioplasty. Radiology
1989;172:937-40.
27. Horvath W, Oertl M, Haidinger D. Percutaneous translumi-
nal angioplasty of crural arteries. Radiology 1990;177:565-9.
28. Bull PG, Mendel H, Hold M, et al. Distal popliteal and
tibioperoneal transluminal angioplasty: Long-term follow-
up. JVIR 1992;3:45-53.
Submitted Jan 9, 1998; accepted Jul 20, 1998.
BOUND VOLUMES AVAILABLE TO SUBSCRIBERS
Bound volumes of the Journal of Vascular Surgery for 1999 are available to subscribers only. They may
be purchased from the publisher at a cost of $119.00 for domestic, $147.66 for Canadian, and $138.00
for international subscribers for Vol 29 (January to June) and Vol 30 (July to December). Price includes
shipping charges. Each bound volume contains a subject and author index, and all advertising is removed.
Copies are shipped within 60 days after publication of the last issue in the volume. The binding is durable
buckram with the journal name, volume number, and year stamped in gold on the spine. Payment must
accompany all orders. Contact Subscription Services, Mosby, Inc, 11830 Westline Industrial Dr, St Louis,
MO 63146-3318, USA. In the United States call toll free 800-325-4177, ext 4351. In Missouri or for-
eign countries call 314-453-4351.
Subscriptions must be in force to qualify. Bound volumes are not available in place of a regular Journal
subscription.
